FORCE Blog

This blog will cover topics of interest that affect our community. Unless otherwise stated, the blog articles will be written by Sue Friedman, Executive Director of FORCE.

| More

FORCE Blog

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 7,709 other subscribers

Archives

Posts Tagged ‘genetic testing’

May 30, 2019

Alert: Cancer Genetic Testing Should Be Performed in the Health Care Setting

by Lisa Schlager and Sue Friedman There is a flood of information available about genetic tests for cancer risk in the media, and even at community events, such as health fairs and senior centers. If these promotions have caught your attention and you are considering testing, there is important information that you should know first. … + read more

April 11, 2019

We All Love a Good Book or Movie

Some books and movies make us think.  Some make us laugh or cry. Some are educational and others are just plain fun.  And, then some do all of the above.  Below is a list of personal memoirs, self-help and reference books created to share information and stories of those who have experienced hereditary cancer. You … + read more

March 8, 2019

XRAYS Blog – A Deep Dive into Disparities: The Challenges and Opportunities of Reaching Out to the Underserved

By Amy Wu I recently had the privilege of spending two days at a brainstorming session with a group of doctors, scientists, researchers, advocates and fellow survivors (myself included), all of us a sounding board for the California Breast Cancer Research Program. The goal was to identify and create research projects on breast cancer. One … + read more

January 22, 2019

My BRCA2 Story: Mastectomy Without Reconstruction

by Marla Ruhana In the XRAYS review, Juliet’s story: No reconstruction is a post-mastectomy option, Juliet’s experience resonated with me. My mastectomy journey began in August of 2003, when my sister called and said, “Well, I’m one of the seven percent of women who get breast cancer under the age of 40.” She said that … + read more

January 10, 2019

Book: The Big Discovery

My Family History In 2003, my mother was diagnosed with stage IV metastatic breast cancer and unfortunately lost her four-year battle at the young of age 52. Shortly after my mother’s battle with cancer, my father was diagnosed with prostate cancer at age 53. He elected to have his prostate removed and is currently doing … + read more

December 31, 2018

New Year’s Then (20 Years Ago) and Now

by Sue Friedman Happy 20th anniversary to FORCE and our community! I founded FORCE on New Year’s Eve, 1998, just a few strokes before midnight. It had been a year of great personal challenge and change for me. I was 35, had just completed treatment for recurrent breast cancer, learned I had a BRCA2 mutation, … + read more

November 28, 2018

You Don’t Need a Family History of Cancer to Benefit from Genetic Testing

by Sue Friedman Many people mistakenly believe that genetic testing for inherited mutations in BRCA1, BRCA2, Lynch Syndrome, and other genes is only appropriate for people with many cases of cancer in their family. National guidelines—based on the latest research—state otherwise. There are situations where a single case of cancer in a family is enough … + read more

September 28, 2018

Addressing Previvors’ Needs for Affordable Access to Care

by Lisa Schlager (Note: Adapted from an article in the September 2018 issue of The Oncology Nurse) In 2010, FORCE spearheaded passage of a Congressional resolution declaring the first-ever National Hereditary Breast and Ovarian Cancer Week and National Previvor Day. This year, Previvor Day is October 3rd. Over the past 8 years, the number of people … + read more

September 21, 2018

Headline Hype: Media Report on BRCA1 Variant Research Plays on Fears

by Piri Welcsh, PhD Most people who have genetic testing for BRCA1, BRCA2 or other genes associated with cancer risk receive either a positive or a negative test result. A positive genetic test result indicates that a change called a mutation was found in a gene which is associated with increased cancer risk. A negative genetic test … + read more

September 12, 2018

Starting a Conversation about My Family Health History

by Shannon Pulaski Ten days into my journey into parenthood, my own mother was diagnosed with ovarian cancer.  It shook my family’s entire world.  And when the earthquake settled, we realized we were only just beginning to understand our new reality.  We were fortunate that her doctor knew to test her for the BRCA gene.  … + read more

July 11, 2018

Where’s FORCE? May and June

by Lisa Schlager “Where’s FORCE” features an overview of the many places our staff and volunteers have been and the many ways we have spoken out for the community in the past couple of months. May “Financial Toxicity” is a term used to describe the impact of health care costs on patients and their families. … + read more

June 14, 2018

XRAYS Blog: Me and My MSH6 Mutation: Ever Searching for Answers

by Aya It all started with Mother’s histopathology report on her partially resected small bowel. She had small bowel cancer. With my middle name being “I-want-to-know-more,” I asked for a pathology report after a post-op consultation with her surgeon where future management was discussed.  When I read the report at home, I noticed an aspect … + read more

May 30, 2018

Where’s FORCE? March and April

by Lisa Schlager “Where’s FORCE” highlights the ongoing efforts of FORCE staff and volunteers on behalf of the community. March As a member of the Bayer Oncology Patient Advocacy Advisory Council (PAAC), FORCE Vice President of Public Policy Lisa Schlager joined representatives from other advocacy groups and Bayer to review project proposals submitted by nonprofit … + read more

April 12, 2018

PARP Inhibitors and Hereditary Cancer: What’s New?

by Sue Friedman PARP inhibitors are drugs designed specifically to treat cancers in people with certain inherited mutations, including BRCA1 and BRCA2, among others. These drugs block an enzyme – known as PARP – used by cells to repair damage to their DNA. Although these agents seem to be most effective in people with mutations—not just … + read more

October 23, 2017

No Longer Alone: 1000 People Benefit from Personalized Cancer Risk Support

by Sandy Cohen Unfortunately, my story is not that uncommon. I’m a motherless daughter. I lost my mom to breast cancer when I was 26 years old. And she lost her mom to the disease before she graduated high school. This all occurred before the BRCA1 mutation was even discovered. Today, thanks to FORCE’s programs, … + read more

Connect with others.

Call our Helpline

Our helpline offers peer support for people concerned about hereditary cancer. All calls are confidential. Call any time.

Join a Local Group

FORCE has outreach groups throughout the United States and in Essex, United Kingdom that meet periodically to offer peer support, and share resources.

FORCE:Facing Our Risk of Cancer Empowered